Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Johnson

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
European Journal of Sport Science|June 20, 2019
Growing pains: Maturity associated variation in injury risk in academy footballD M Johnson, S Williams, B Bradley, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1992
Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolatesB B Gooding, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 1998
In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysisR N Jones, C H Ballow, J J Schentag, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2000
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridoneR N Jones, M E Erwin, D J Biedenbach, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella speciesD M Johnson, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporinB M Briggs, R N Jones, M E Erwin, et al.
British Journal of Pharmacology|November 30, 2011
The electro-mechanical window in anaesthetized guinea pigs: a new marker in screening for Torsade de Pointes riskP-J Guns, D M Johnson, J Van Op den Bosch, et al.
Diagnostic Microbiology and Infectious Disease|June 23, 2000
Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus speciesD M Johnson, D J Biedenbach, M L Beach, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628M S Barrett, R N Jones, M E Erwin, et al.
AJNR. American Journal of Neuroradiology|February 2, 2008
Neurologic complications of inferior petrosal sinus samplingC D Gandhi, S A Meyer, A B Patel, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
European Journal of Sport Science|June 20, 2019
Growing pains: Maturity associated variation in injury risk in academy footballD M Johnson, S Williams, B Bradley, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1992
Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolatesB B Gooding, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 1998
In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysisR N Jones, C H Ballow, J J Schentag, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2000
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridoneR N Jones, M E Erwin, D J Biedenbach, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella speciesD M Johnson, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporinB M Briggs, R N Jones, M E Erwin, et al.
British Journal of Pharmacology|November 30, 2011
The electro-mechanical window in anaesthetized guinea pigs: a new marker in screening for Torsade de Pointes riskP-J Guns, D M Johnson, J Van Op den Bosch, et al.
Diagnostic Microbiology and Infectious Disease|June 23, 2000
Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus speciesD M Johnson, D J Biedenbach, M L Beach, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628M S Barrett, R N Jones, M E Erwin, et al.
AJNR. American Journal of Neuroradiology|February 2, 2008
Neurologic complications of inferior petrosal sinus samplingC D Gandhi, S A Meyer, A B Patel, et al.
Pageof 12